AC
AHCO icon

Aristeia Capital’s AdaptHealth AHCO Stock Holding History

Aristeia Capital’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75,174
Closed -$749K – 699
2025
Q4 		$749K Buy
+75,174
New +$718K 0.02% 263
2024
Q2 		– Sell
-33,245
Closed -$383K – 340
2024
Q1 		$383K Buy
+33,245
New +$282K 0.01% 124
2019
Q4 		– Sell
-1,319,551
Closed -$13.4M – 55
2019
Q3 		$13.4M Buy
+1,319,551
New +$13.5M 0.78% 23

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristeia Capital's AHCO Position: Q1 2026 in Review

Aristeia Capital sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 75,174 shares — an estimated $749K sold.

Aristeia Capital first reported a position in AHCO in Q3 2019 and held it in 3 quarters. The position peaked at $13.4M in Q3 2019. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Aristeia Capital reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • Aristeia Capital sold 75,174 AdaptHealth shares in Q1 2026, an estimated $749K.
  • Aristeia Capital first reported a position in AdaptHealth in Q3 2019 and held it in 3 quarters.
  • Aristeia Capital's AdaptHealth position peaked at $13.4M in Q3 2019.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Aristeia Capital's 13F filing for Q1 2026, filed 15 May 2026.